Effects of probenecid and cimetidine on the pharmacokinetics of nemonoxacin in healthy Chinese volunteers | |
Zhang, YF; Dai, XJ; Yang, Y; Chen, XY; Wang, T; Tang, YB; Tsai, CY; Chang, LW; Chang, YT; Zhong, DF | |
刊名 | DRUG DESIGN DEVELOPMENT AND THERAPY |
2016 | |
卷号 | 10页码:357-370 |
关键词 | nemonoxacin probenecid cimetidine clinical pharmacokinetics drug-drug interaction |
ISSN号 | 1177-8881 |
文献子类 | Article |
英文摘要 | Purpose: To investigate the effects of probenecid and cimetidine on the pharmacokinetics of nemonoxacin in humans. Methods: Two independent, open-label, randomized, crossover studies were conducted in 24 (12 per study) healthy Chinese volunteers. In Study 1, each volunteer received a single oral dose of 500 mg of nemonoxacin alone or with 1.5 g of probenecid divided into three doses within 25 hours. In Study 2, each volunteer received a single oral dose of 500 mg of nemonoxacin alone or with multiple doses of cimetidine (400 mg thrice daily for 7 days). The plasma and urine nemonoxacin concentrations were determined using validated liquid chromatography-tandem mass spectrometry methods. Results: Coadministration of nemonoxacin with probenecid reduced the renal clearance (CLr) of nemonoxacin by 22.6%, and increased the area under the plasma concentration-time curve from time 0 to infinity (AUC(0-8)) by 26.2%. Coadministration of nemonoxacin with cimetidine reduced the CLr of nemonoxacin by 13.3% and increased AUC(0-8) by 9.4%. Coadministration of nemonoxacin with probenecid or cimetidine did not significantly affect the maximum concentration of nemonoxacin or the percentage of the administered dose recovered in the urine. Conclusion: Although probenecid reduced the CLr and increased the plasma exposure of nemonoxacin, these effects are unlikely to be clinically meaningful at therapeutic doses. Cimetidine had weaker, clinically meaningless effects on the pharmacokinetics of nemonoxacin. |
学科主题 | Pharmacology & Pharmacy |
出版地 | ALBANY |
资助项目 | 国家科技重大专项 |
项目编号 | National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program" of China [2012ZX0931-001] |
语种 | 英语 |
WOS记录号 | WOS:000368487900003 |
资助机构 | MOST |
内容类型 | 期刊论文 |
源URL | [http://ir.lzu.edu.cn/handle/262010/178542] |
专题 | 第一临床医学院_期刊论文 |
通讯作者 | Zhong, DF (reprint author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, 501 Haike Rd, Shanghai 201203, Peoples R China. |
推荐引用方式 GB/T 7714 | Zhang, YF,Dai, XJ,Yang, Y,et al. Effects of probenecid and cimetidine on the pharmacokinetics of nemonoxacin in healthy Chinese volunteers[J]. DRUG DESIGN DEVELOPMENT AND THERAPY,2016,10:357-370. |
APA | Zhang, YF.,Dai, XJ.,Yang, Y.,Chen, XY.,Wang, T.,...&Zhong, DF .(2016).Effects of probenecid and cimetidine on the pharmacokinetics of nemonoxacin in healthy Chinese volunteers.DRUG DESIGN DEVELOPMENT AND THERAPY,10,357-370. |
MLA | Zhang, YF,et al."Effects of probenecid and cimetidine on the pharmacokinetics of nemonoxacin in healthy Chinese volunteers".DRUG DESIGN DEVELOPMENT AND THERAPY 10(2016):357-370. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论